A carregar...
Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors
PURPOSE: Peptide drugs for antineoplastic therapies usually have low oral bioavailability and short in vivo half-lives, requiring less preferred delivery methods. Lanreotide depot is a sustained-release somatostatin analog (SSA) formulation produced via an innovative peptide self-assembly method. La...
Na minha lista:
| Publicado no: | J Gastrointest Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5138269/ https://ncbi.nlm.nih.gov/pubmed/27619395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12029-016-9866-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|